NVE CORP (NVEC)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NVEC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NVEC | 48 | ["Experience as a director at other publicly-traded companies","Experience in electronics or semiconductor industries","Financial expert","Experience managing cybersecurity risks","Artificial intelligence expertise","Experience managing employee health and safety","Independent of Management"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Kelly Wei has been a director since May 2024. She is Vice President of Corporate Strategy at Medtronic plc. Dr. Wei has held various scientific, engineering, management, and senior management positions at Medtronic since 2007. She started her career as a senior research scientist in cardiac rhythm and disease management at Boston Scientific Corporation in 2004. Dr. Wei has been a member of the Board of Trustees of the Williams Syndrome Association since 2021, and a member of the Board of Directors of Abova, Inc. since February 2024. Abova is a privately-held oral and overall health, technology and science-driven company. She is also a certified executive coach. Dr. Wei has a Ph.D. in Electrical Engineering and an M.S. in Computer Engineering from Rensselaer Polytechnic Institute, an M.S. in Integrative Biology and Physiology from the University of Minnesota Medical School, and a B.S. in Electrical Engineering from Huazhong University of Science and Technology. Dr. Wei s management, technical, and medical device experience, and her engineering and medical education qualify her to serve as a director.